MedTrace Logo

Long-term Study of Epiduo in Patients With Moderate to Severe Acne

NCT01618773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6036

Last updated 2016-02-17

No results posted yet for this study

Summary

This observational study is designed to assess the long-term efficacy and safety of Epiduo (alone or in combination with other drugs) under daily clinical practice conditions in patients with moderate to severe inflammatory acne. In addition, the effect of Epiduo on quality of life and patient adherence will be assessed under marketed conditions.

Conditions

  • Acne Vulgaris

Interventions

DRUG

0.1% adapalene / 2.5% benzoyl peroxide

topical application

Sponsors & Collaborators

  • Galderma Laboratorium GmbH

    lead INDUSTRY

Principal Investigators

  • Harald PM Gollnick, Prof. Dr. · Universitätsklinikum Magdeburg A.ö.R. Klinik für Dermatologie und Venerologie

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01618773 on ClinicalTrials.gov